Bliss GVS Pharma Experiences Revision in Its Stock Evaluation Amid Market Volatility
The small-cap segment of the market has demonstrated resilience, with a modest increase of 0.11%. Bliss GVS Pharma stands out with impressive returns, while Nilkamal Ltd struggles amid mixed sector performance. The advance-decline ratio reflects ongoing volatility, with 442 stocks advancing and 516 declining. Investors are closely monitoring upcoming earnings reports from companies like GE Shipping Co and Sundram Fasteners, which may impact market trends. Additionally, several stocks, including Kingfa Science and KEI Industries, have received upgraded assessments, signaling a shift in market sentiment.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
